Infectious Disease Immunoassay Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease Immunoassay Market 

5.1. COVID-19 Landscape: Infectious Disease Immunoassay Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease Immunoassay Market, By Product Type

8.1. Infectious Disease Immunoassay Market, by Product Type

8.1.1. Reagents and Kits

8.1.1.1. Market Revenue and Forecast

8.1.2. Instruments and Analyzers

8.1.2.1. Market Revenue and Forecast

8.1.3. Calibrators

8.1.3.1. Market Revenue and Forecast

8.1.4. Controls

8.1.4.1. Market Revenue and Forecast

8.1.5. Software and Data Management Solutions

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Infectious Disease Immunoassay Market, By Technology

9.1. Infectious Disease Immunoassay Market, by Technology

9.1.1. Chemiluminescent Immunoassay

9.1.1.1. Market Revenue and Forecast

9.1.2. Enzyme-Linked Immunosorbent Assay

9.1.2.1. Market Revenue and Forecast

9.1.3. Fluorescent Immunoassay

9.1.3.1. Market Revenue and Forecast

9.1.4. Radioimmunoassay

9.1.4.1. Market Revenue and Forecast

9.1.5. Rapid Lateral Flow Immunoassay

9.1.5.1. Market Revenue and Forecast

9.1.6. Multiplex Immunoassay

9.1.6.1. Market Revenue and Forecast  

Chapter 10. Global Infectious Disease Immunoassay Market, By Test Type

10.1. Infectious Disease Immunoassay Market, by Test Type

10.1.1. Antigen Detection Immunoassays

10.1.1.1. Market Revenue and Forecast

10.1.2. Antibody Detection Immunoassays

10.1.2.1. Market Revenue and Forecast

10.1.3. Combined Antigen and Antibody Immunoassays

10.1.3.1. Market Revenue and Forecast

10.1.4. Confirmatory Immunoassays

10.1.4.1. Market Revenue and Forecast

10.1.5. Quantitative Immunoassays

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Infectious Disease Immunoassay Market, By Disease Type

11.1. Infectious Disease Immunoassay Market, by Disease Type

11.1.1. HIV Immunoassays

11.1.1.1. Market Revenue and Forecast

11.1.2. Hepatitis Immunoassays

11.1.2.1. Market Revenue and Forecast

11.1.3. Respiratory Infection Immunoassays

11.1.3.1. Market Revenue and Forecast

11.1.4. TORCH Infection Immunoassays

11.1.4.1. Market Revenue and Forecast

11.1.5. Sexually Transmitted Infection Immunoassays

11.1.5.1. Gastrointestinal Infection Immunoassays

11.1.6. Tropical and Vector-Borne Disease Immunoassays

11.1.6.1. Market Revenue and Forecast

11.1.7. Healthcare-Associated Infection Immunoassays

11.1.7.1. Market Revenue and Forecast

Chapter 12. Global Infectious Disease Immunoassay Market, By Application

12.1. Infectious Disease Immunoassay Market, by Application

12.1.1. Screening

12.1.1.1. Market Revenue and Forecast

12.1.2. Diagnostic Testing

12.1.2.1. Market Revenue and Forecast

12.1.3. Disease Monitoring

12.1.3.1. Market Revenue and Forecast

12.1.4. Blood Screening

12.1.4.1. Market Revenue and Forecast

12.1.5. Epidemiological Surveillance

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global Infectious Disease Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type

13.1.2. Market Revenue and Forecast, by Technology

13.1.3. Market Revenue and Forecast, by Test Type

13.1.4. Market Revenue and Forecast, by Disease Type

13.1.5. Market Revenue and Forecast, by Application

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type

13.1.6.2. Market Revenue and Forecast, by Technology

13.1.6.3. Market Revenue and Forecast, by Test Type

13.1.6.4. Market Revenue and Forecast, by Disease Type

13.1.6.5. Market Revenue and Forecast, by Application  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type

13.1.7.2. Market Revenue and Forecast, by Technology

13.1.7.3. Market Revenue and Forecast, by Test Type

13.1.7.4. Market Revenue and Forecast, by Disease Type

13.1.7.5. Market Revenue and Forecast, by Application

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type

13.2.2. Market Revenue and Forecast, by Technology

13.2.3. Market Revenue and Forecast, by Test Type

13.2.4. Market Revenue and Forecast, by Disease Type  

13.2.5. Market Revenue and Forecast, by Application  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type

13.2.6.2. Market Revenue and Forecast, by Technology

13.2.6.3. Market Revenue and Forecast, by Test Type

13.2.7. Market Revenue and Forecast, by Disease Type  

13.2.8. Market Revenue and Forecast, by Application  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type

13.2.9.2. Market Revenue and Forecast, by Technology

13.2.9.3. Market Revenue and Forecast, by Test Type

13.2.10. Market Revenue and Forecast, by Disease Type

13.2.11. Market Revenue and Forecast, by Application

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type

13.2.12.2. Market Revenue and Forecast, by Technology

13.2.12.3. Market Revenue and Forecast, by Test Type

13.2.12.4. Market Revenue and Forecast, by Disease Type

13.2.13. Market Revenue and Forecast, by Application

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type

13.2.14.2. Market Revenue and Forecast, by Technology

13.2.14.3. Market Revenue and Forecast, by Test Type

13.2.14.4. Market Revenue and Forecast, by Disease Type

13.2.15. Market Revenue and Forecast, by Application

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type

13.3.2. Market Revenue and Forecast, by Technology

13.3.3. Market Revenue and Forecast, by Test Type

13.3.4. Market Revenue and Forecast, by Disease Type

13.3.5. Market Revenue and Forecast, by Application

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type

13.3.6.2. Market Revenue and Forecast, by Technology

13.3.6.3. Market Revenue and Forecast, by Test Type

13.3.6.4. Market Revenue and Forecast, by Disease Type

13.3.7. Market Revenue and Forecast, by Application

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type

13.3.8.2. Market Revenue and Forecast, by Technology

13.3.8.3. Market Revenue and Forecast, by Test Type

13.3.8.4. Market Revenue and Forecast, by Disease Type

13.3.9. Market Revenue and Forecast, by Application

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type

13.3.10.2. Market Revenue and Forecast, by Technology

13.3.10.3. Market Revenue and Forecast, by Test Type

13.3.10.4. Market Revenue and Forecast, by Disease Type

13.3.10.5. Market Revenue and Forecast, by Application

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type

13.3.11.2. Market Revenue and Forecast, by Technology

13.3.11.3. Market Revenue and Forecast, by Test Type

13.3.11.4. Market Revenue and Forecast, by Disease Type

13.3.11.5. Market Revenue and Forecast, by Application

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type

13.4.2. Market Revenue and Forecast, by Technology

13.4.3. Market Revenue and Forecast, by Test Type

13.4.4. Market Revenue and Forecast, by Disease Type

13.4.5. Market Revenue and Forecast, by Application

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type

13.4.6.2. Market Revenue and Forecast, by Technology

13.4.6.3. Market Revenue and Forecast, by Test Type

13.4.6.4. Market Revenue and Forecast, by Disease Type

13.4.7. Market Revenue and Forecast, by Application

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type

13.4.8.2. Market Revenue and Forecast, by Technology

13.4.8.3. Market Revenue and Forecast, by Test Type

13.4.8.4. Market Revenue and Forecast, by Disease Type

13.4.9. Market Revenue and Forecast, by Application

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type

13.4.10.2. Market Revenue and Forecast, by Technology

13.4.10.3. Market Revenue and Forecast, by Test Type

13.4.10.4. Market Revenue and Forecast, by Disease Type

13.4.10.5. Market Revenue and Forecast, by Application

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type

13.4.11.2. Market Revenue and Forecast, by Technology

13.4.11.3. Market Revenue and Forecast, by Test Type

13.4.11.4. Market Revenue and Forecast, by Disease Type

13.4.11.5. Market Revenue and Forecast, by Application

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type

13.5.2. Market Revenue and Forecast, by Technology

13.5.3. Market Revenue and Forecast, by Test Type

13.5.4. Market Revenue and Forecast, by Disease Type

13.5.5. Market Revenue and Forecast, by Application

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type

13.5.6.2. Market Revenue and Forecast, by Technology

13.5.6.3. Market Revenue and Forecast, by Test Type

13.5.6.4. Market Revenue and Forecast, by Disease Type

13.5.7. Market Revenue and Forecast, by Application

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type

13.5.8.2. Market Revenue and Forecast, by Technology

13.5.8.3. Market Revenue and Forecast, by Test Type

13.5.8.4. Market Revenue and Forecast, by Disease Type

13.5.8.5. Market Revenue and Forecast, by Application

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. F. Hoffmann-La Roche Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. bioMérieux SA

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Siemens Healthineers AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Beckman Coulter, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. QuidelOrtho Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Thermo Fisher Scientific Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Danaher Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Sysmex Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Becton, Dickinson and Company

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms